Diagnosis of prion diseases by RT-QuIC results in improved surveillance

Objective To present the National Prion Disease Pathology Surveillance Center's (NPDPSC’s) experience using CSF real-time quaking-induced conversion (RT-QuIC) as a diagnostic test, to examine factors associated with false-negative RT-QuIC results, and to investigate the impact of RT-QuICs on prion disease surveillance. Methods Between May 2015 and April 2018, the NPDPSC received 10,498 CSF specimens that were included in the study. Sensitivity and specificity analyses were performed on 567 autopsy-verified cases. Prion disease type, demographic characteristics, specimen color, and time variables were examined for association with RT-QuIC results. The effect of including positive RT-QuIC cases in prion disease surveillance was examined. Results The diagnostic sensitivity and specificity of RT-QuIC across all prion diseases were 90.3% and 98.5%, respectively. Diagnostic sensitivity was lower for fatal familial insomnia, Gerstmann-Sträussler-Scheinker disease, sporadic fatal insomnia, variably protease sensitive prionopathy, and the VV1 and MM2 subtypes of sporadic Creutzfeldt-Jakob disease. Individuals with prion disease and negative RT-QuIC results were younger and had lower tau levels and nonelevated 14-3-3 levels compared to RT-QuIC–positive cases. Sensitivity was high throughout the disease course. Some cases that initially tested RT-QuIC negative had a subsequent specimen test positive. Including positive RT-QuIC cases in surveillance statistics increased laboratory-based case ascertainment of prion disease by 90% over autopsy alone. Conclusions RT-QuIC has high sensitivity and specificity for diagnosing prion diseases. Sensitivity limitations are associated with prion disease type, age, and related CSF diagnostic results. RT-QuIC greatly improves laboratory-based prion disease ascertainment for surveillance purposes. Classification of evidence This study provides Class III evidence that second-generation RT-QuIC identifies prion disease with a sensitivity of 90.3% and specificity of 98.5% among patients being screened for these diseases due to concerning symptoms.

[1]  Michael T. Osterholm,et al.  Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species , 2019, mBio.

[2]  B. Appleby,et al.  Therapeutic strategies for prion disease: a practical perspective. , 2019, Current opinion in pharmacology.

[3]  W. Schulz-Schaeffer,et al.  Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance , 2018, Neurology.

[4]  O. Andréoletti,et al.  The zoonotic potential of animal prion diseases. , 2018, Handbook of clinical neurology.

[5]  B. Caughey,et al.  High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions , 2017, Scientific Reports.

[6]  B. Caughey,et al.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid , 2017, Annals of neurology.

[7]  B. Caughey,et al.  Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid , 2015, mBio.

[8]  A. Bizzi,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.

[9]  I. Capek,et al.  Can Mortality Data Provide Reliable Indicators for Creutzfeldt-Jakob Disease Surveillance? A Study in France from 2000 to 2008 , 2011, Neuroepidemiology.

[10]  R. Holman,et al.  Human Prion Diseases in the United States , 2010, PloS one.

[11]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[12]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.